• We care about rare disease patients

    Sobi is dedicated to develop and deliver innovative therapies to improve the lives of rare disease patients

    Learn more about Sobi

Rare Diseases

Rare diseases affect small groups of patients and are often life-threatening or causing chronic disability. In total there are about 7,000 known rare diseases but only about 400 approved treatments.

More about rare diseases

Our Products

Sobi’s product portfolio is primarily focused on Inflammation and Genetic diseases, with two late stage biological development projects within Haemophilia. We also market a portfolio of specialty and rare disease products for partner companies.

More about our products

Transparency - we support

Swedish Orphan Biovitrum UK believes in transparency. Payments made to healthcare professionals and their staff, funding to patient groups, support made to organisations and sponsorship for delegates to attend congresses are declared as per the ABPI code of practice.

More about transparency

We support

  • Climb
  • Great Ormond Street Hospital
  • HAE UK
  • UK Thalassemia Society

Our Therapy Areas

  • Autoimmune
  • Autoinflammatory
  • Genetics
  • Hematology
  • Inherited Metabolic Diseases
  • Rheumatology
  • Dupuytren’s Contracture

Read more